Impaired intestinal barrier function measured by differently sized polyethylene glycols in patients with chronic renal failure.
about
The Gut as a Source of Inflammation in Chronic Kidney DiseaseInsulin resistance in chronic kidney disease: a systematic review.Endotoxemia is associated with acute coronary syndrome in patients with end stage kidney diseaseThe colon: an overlooked site for therapeutics in dialysis patients.The gut microbiome, kidney disease, and targeted interventions.The Influence of CKD on Colonic Microbial Metabolism.Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD.Fecal Transplants: What Is Being Transferred?Type 2 Diabetes Mellitus Is Associated with More Serious Small Intestinal Mucosal Injuries.TLR4 mutant mice are protected from renal fibrosis and chronic kidney disease progressionSerum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden.Vitamin D3 repletion in chronic kidney disease stage 3: effects on blood endotoxin activity, inflammatory cytokines, and intestinal permeability.Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease.Uremic plasma impairs barrier function and depletes the tight junction protein constituents of intestinal epithelium.CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity.Clinical causes of inflammation in peritoneal dialysis patients.Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis.The intestine and the kidneys: a bad marriage can be hazardous.Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment.Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies.Report of the National Heart, Lung, and Blood Institute Working Group on the Role of Microbiota in Blood Pressure Regulation: Current Status and Future Directions.Gut microbiome in chronic kidney disease: challenges and opportunities.Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation.Mode of renal replacement therapy determines endotoxemia and neutrophil dysfunction in chronic kidney disease.Measurement of the intestinal permeability in chronic kidney disease.The chemistry of aluminium in the gastrointestinal lumen and its uptake and absorption.The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial.Aluminum exposure and metabolism.Oral activated charcoal adsorbent (AST-120) ameliorates chronic kidney disease-induced intestinal epithelial barrier disruptionThe increased intestinal absorption rate is responsible for the reduced hepatic first-pass extraction of propranolol in rats with cisplatin-induced renal dysfunction.Structural and functional differences in gut microbiome composition in patients undergoing haemodialysis or peritoneal dialysis.The Chronic Kidney Disease - Colonic Axis.Extensive lanthanum deposition in the gastric mucosa: the first histopathological report.Conjugated metabolites represent the major circulating forms of Abelmoschus manihot in vivo and show an altered pharmacokinetic profile in renal pathology.Gut Microbiome in Chronic Kidney Disease.Intestinal bacterial microflora--a potential source of chronic inflammation in patients with chronic kidney disease.Increased Intestinal Permeability and Decreased Barrier Function: Does It Really Influence the Risk of Inflammation?Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients.
P2860
Q28081781-C3F3CC36-26E0-4997-B829-36D76A8F5C05Q30244271-ADD45390-87E6-4B04-A657-04D760894E2CQ33901115-087742A7-73F0-48FE-ABAF-2D4C5E37A349Q34607428-41594A43-8131-47B8-BA66-BACA79631F4DQ35042986-ACE9DDA4-3393-4EDD-A465-79CD57055E11Q35786047-3F93A0CE-7514-4744-A44E-DB871F08106FQ36025615-7DE11E31-3CDB-495E-8464-EEB4356F21E9Q36073899-86EDFE1C-E555-4D68-8033-84208B2B7B84Q36123785-1190FECA-06EB-45F8-96B4-93438C4BC65FQ36144601-266428DB-3395-454B-A6B0-33F1912928E0Q36417895-1E9DD415-D446-4C58-95DE-166DA785E459Q36896547-241D1277-1B85-40E4-B2D6-958E90A58EA6Q36940342-9F5DA206-C0A6-4C74-94AB-AEB67509C285Q37050237-63002BA3-B97B-4F3D-B959-4B22471EA1CBQ37131182-51CBA9AC-8C66-4120-89AD-05ABB16E7D37Q38217488-62746945-FC04-492B-978E-BFED6BC8B1B2Q38222867-90CA75B0-A6E1-4AAB-A633-86D89CAD680AQ38393212-8D8E897F-CD36-4459-A19A-C68773B4802BQ38425357-FC3E3712-4DDD-4D3D-AC98-0FB57087F151Q38636372-DB3E60FA-9F53-4D33-98D0-2640BFBC479AQ38649038-8A67BF2F-97A5-4CAF-A354-8CEE0171D7E1Q38836354-A0D517B0-3CD7-4DF1-8E52-2777604385B2Q39598955-5A48954E-4449-44A3-9DF4-FCC6C5AA82ECQ40518328-0293E235-AA32-41EF-BDAD-8022EE9E13BBQ40599724-49AE5DDE-F212-42FD-A851-108865CD0472Q40907179-F31D504F-E9D3-48D9-93BB-CC942B328C8DQ41529290-08EBF706-3B84-4F86-8D13-363CC847A02EQ41666262-16864F7D-3776-45E0-B8E7-4DC8040A2D5BQ42042998-DA5BF943-C1F6-461C-8ED4-961D42DDDF73Q44476289-71FC6BE5-4B32-4E70-AAB3-912BF4938FA2Q46260769-EE92A0E7-AADD-40D9-9ED4-CC968D76B596Q46415279-3E7CAAA6-CA0A-4BDA-A36D-32831C047DDAQ51075765-D819C215-87F9-4D46-9A92-8D7CF004EC04Q51842797-9CE52C1A-D8CC-450C-B8E9-FA4B21F4796EQ52680146-8127A197-C6A4-4B44-82E1-460A61742313Q55042067-F2FCB230-5D2D-49EC-A28F-64DB6E6F6DEEQ55252106-6EB21389-2460-440B-AB53-4096DC148CF9Q55439721-53E11282-5F2C-43AB-AD60-0417783B8A26
P2860
Impaired intestinal barrier function measured by differently sized polyethylene glycols in patients with chronic renal failure.
description
1991 nî lūn-bûn
@nan
1991 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Impaired intestinal barrier fu ...... ts with chronic renal failure.
@ast
Impaired intestinal barrier fu ...... ts with chronic renal failure.
@en
Impaired intestinal barrier fu ...... ts with chronic renal failure.
@nl
type
label
Impaired intestinal barrier fu ...... ts with chronic renal failure.
@ast
Impaired intestinal barrier fu ...... ts with chronic renal failure.
@en
Impaired intestinal barrier fu ...... ts with chronic renal failure.
@nl
prefLabel
Impaired intestinal barrier fu ...... ts with chronic renal failure.
@ast
Impaired intestinal barrier fu ...... ts with chronic renal failure.
@en
Impaired intestinal barrier fu ...... ts with chronic renal failure.
@nl
P2093
P2860
P356
P1433
P1476
Impaired intestinal barrier fu ...... ts with chronic renal failure.
@en
P2093
Denneberg T
Magnusson M
Sundqvist T
P2860
P304
P356
10.1136/GUT.32.7.754
P407
P577
1991-07-01T00:00:00Z